After a median follow-up of 13.3 months (95% CI, 9.04-18.69), the median duration of response was 18.1 months, progression ...

Richter transformation develops in 2%–10% of CLL cases, often with rapid clinical decline, limited chemotherapy efficacy, and ...

As employers grapple with the soaring demand for glucagon-like peptide-1 (GLP-1) medications, Eric Levin, CEO and cofounder ...

Personal factors explained significant variance in five of six participation outcomes (R² 13%–48%), while environmental factors added ~11% for satisfaction and ~11% for GPS-based activity. Perceived ...

Among patients with steatotic liver disease (SLD), patients with alcohol-associated liver disease (ALD) carry the highest risk of cirrhosis, followed by those with metabolic dysfunction–associated ...

Clinical measures and biomarkers during pregnancy, including hs-cTnI and sFlt-1, can help identify women at higher risk of developing cardiovascular disease later in life.